FTSE100 - Page 6

18 September 2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis New indication supported by the MANDARA trial which showed nearly 60% of…

GSK plc (LSE/NYSE: GSK) today announced that it has completed the primary objective data analysis from the phase II part of the TH HSV…

2 September 2024 LONDONMETRIC PROPERTY PLC LONDONMETRIC TRANSACTS ON £120 MILLION OF ACQUISITIONS AND DISPOSALS LondonMetric Property Plc (“LondonMetric” or “Company”) announces that it has…

Diageo delivers resilient performance with improved market share in the second half of the fiscal year, despite volatile operating environment –    Reported net sales of $20.3…

Fixed-duration Calquence plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukaemia in AMPLIFY Phase III trial Favourable trend in overall survival…

FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results The Food and Drug Administration’s (FDA)…

RELX, the global provider of information-based analytics and decision tools, reports results for the first half of 2024 and reaffirms the full year outlook….

“In the first six months of 2024, the Group delivered robust financial results with solid income performance and cost discipline alongside strong capital generation….